Steroids for Pets Market
Report ID: SQMIG35I2521
Report ID: SQMIG35I2521
sales@skyquestt.com
USA +1 351-333-4748
Report ID:
SQMIG35I2521 |
Region:
Global |
Published Date: February, 2026
Pages:
157
|Tables:
116
|Figures:
77
Global Steroids For Pets Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.01 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
The primary driver of the steroids for pets market is the rising prevalence of chronic inflammatory and immune-mediated conditions in companion animals combined with stronger owner willingness to invest in veterinary care. This market encompasses corticosteroid and related formulations used to control inflammation, allergies, autoimmune disorders and perioperative inflammation, and it matters because these therapies deliver rapid symptom relief, improve quality of life and generate recurring prescription demand for clinics. Over time the sector moved from sporadic off-label use to standardized veterinary formulations, broader generic availability and online retail channels; for example, prednisone shifted from hospital stock to common outpatient prescriptions and topical steroids became routine in dermatology practice.
Building on that trajectory, a key trend driving global steroids for pets sector expansion is improved access and shifting treatment paradigms that convert clinical need into commercial growth. Availability of generics and online pharmacies reduces cost and friction, causing higher prescription volumes for conditions such as canine atopic dermatitis and feline asthma where oral or inhaled steroids remain primary options. The increase in regular wellness screenings along with increased use of pet insurance have led to more pets being diagnosed than ever before, which leads to more pets being treated with long-term steroids as well as providing opportunities for long-acting injectable products and topical innovation and steroid alternatives.
How is AI Enhancing Safety Monitoring in the Steroids for Pets Market?
AI is strengthening safety monitoring in the steroids for pets market by combining predictive analytics, automated lab interpretation and real world signal detection. Key aspects include electronic health record aggregation, natural language processing of veterinary notes and adverse event reports and AI models that flag abnormal lab trends or behavioral signals after steroid use. Adoption of in-clinic AI diagnostics and cloud pharmacovigilance tools is making monitoring continuous rather than episodic. In a market where owners expect safer treatments and regulators stress post market surveillance examples like AI enhanced CBC analysis and wearable activity tracking help clinicians detect opportunistic infections and dosing issues sooner.
Zoetis in November 2025 announced an AI powered CBC classification for clinic use that enables faster detection of blood changes associated with steroid therapy and triggers real time safety alerts and pharmacovigilance. This reduces clinic workload and builds clinician confidence which supports market growth and treatment efficiency.
Market snapshot - (2026-2033)
Global Market Size
USD 1.1 Billion
Largest Segment
Corticosteroids
Fastest Growth
Anabolic Steroids
Growth Rate
6.9% CAGR
To get more insights on this market click here to Request a Free Sample Report
Global steroids for pets market is segmented by product type, formulation type, animal type, end user and region. Based on product type, the market is segmented into anabolic steroids and corticosteroids. Based on formulation type, the market is segmented into tablets, liquid solutions and powdered form. Based on animal type, the market is segmented into dogs, cats and others. Based on end user, the market is segmented into veterinary clinics, pet owners and pet pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Based on the global steroids for pets market forecast, dogs segment dominates because canine patients represent the primary clinical focus for steroid therapies, with well established diagnostic and treatment pathways that drive frequent prescribing. Veterinary practitioners rely on anabolic protocols for muscle-wasting, recovery, and performance-related conditions in dogs, prompting manufacturers to tailor dosing, palatability, and delivery formats for canine physiology. Strong owner willingness to pursue active treatments further sustains routine demand and supplier prioritization for dog products.
However, cats are becoming the fastest growing animal type due to greater veterinary focus on feline inflammatory and skin disorders, owner demand for chronic care, and the introduction of lower dose and palatable formulations. These drivers are prompting product innovation and treatment pathways, broadening market opportunities for feline steroid therapies.
Liquid Solutions segment dominates because liquids provide flexible dosing and rapid onset that align with both emergency and routine steroid needs across companion animals. Veterinarians prefer liquid presentations for accurate dosing and injecting as well as developing solid formulations that are always stable and have additives (preservatives) so they can be used longer. The ability to use liquid medications clinically and easily in either the clinic or at home has led to the widespread use of liquids throughout both the professional and consumer markets.
Tablets have become one of the fastest growing formulation types due to their convenience, acceptance as chewables and simplified dosing, making it easier for owners to comply with their chronically used steroid medications. Innovations in sustained release and taste masking, along with pharmacy compounding, are widening clinical uses and enabling scalable retail and home care channels, driving future market expansion.
To get detailed segments analysis, Request a Free Sample Report
As per the global steroids for pets market analysis, North America is leading the market. The infrastructure that supports advanced animal medicine is very strong, awareness levels among owners of pets are quite high and there are many established systems that cater to distribution of the products used to treat animals. The development of innovative products is also a driving force behind the wide variety of on-the-shelf products and the different approaches to administering these products in the industries in which they operate.
Regulatory frameworks for testing and certifying a product are very well established (combined with strong co-operation between research institutions as well as the industry) and will facilitate the continued use of clinically validated therapies. The urbanisation of our pet population and the standards we have for providing good quality veterinary care have resulted in routine diagnosis and therapy.
Steroids for pets market in United States reflects a mature ecosystem of clinical expertise, advanced pharmaceutical development, and broad distribution channels. The veterinary education system and the specialty clinic system have raised the bar regarding the evidence-based therapeutic use of the products. Evidence-based therapeutic use is defined as using therapeutic products according to established guidelines and research evidence. Collaboration between industry and academic researchers results in innovative formulations and the safety monitoring of those products.
Steroids for Pets Market in Canada benefits from veterinary networks, strong practitioner training, and collaborative regulatory pathways that facilitate clinical use. A growing emphasis on companion animal welfare and veterinary outreach improves access to therapeutics. Compounding pharmacies and specialized distributors support tailored dosing options while telemedicine platforms extend clinical oversight. Industry engagement with veterinary associations promotes guideline based prescribing, building clinician confidence and encouraging standardized treatment approaches across diverse practice settings.
Rapid expansion of the steroids for pets market in Europe is driven by increasing pet health prioritization, concerted efforts to harmonize regulatory pathways across jurisdictions, and enhanced clinical practice standards. Manufacturers, veterinary associations, and clinical researchers are collaborating to create an evidence-based approach to provide veterinarians with information to support their prescribing practices. Additional support for increasing market penetration includes the willingness of pet owners to invest in costly, new therapies and more comprehensive post-market safety monitoring.
Cross-border partnerships and harmonization of trade across the globe lead to better supply chain logistics, and educational efforts directed at veterinarians and pet owners will lead to enhanced acceptance of steroids for increasing numbers of clinical indications. Regional manufacturers consulting with their customers on how to adapt their business models for the variances within each national market will enhance the distribution system and responsiveness to the veterinarian's needs.
Steroids for Pets Market in Germany reflects a highly developed pharmaceutical and veterinary research environment that underpins leadership in product development and clinical practice. Dense networks of specialty clinics encourage evidence led treatment protocols. Robust capabilities and compliant quality standards provide confidence in the supply chain. Close collaboration with industry and regulatory bodies improves access to the market. Professional development, along with a strong distribution system, leads to widespread clinical usage throughout all types of practices across the United States.
Steroids for Pets Market in United Kingdom demonstrates dynamic expansion driven by digital veterinary services, strong private clinic networks, and elevated pet owner engagement. Access to care and faster treatment through telehealth. Professional training as well as a proactive clinical environment supports the adoption of formulation products. The collaboration between the industry and veterinary associations aids in generating guidelines. Continued strength of the market is driven by consumer demand for greater access to advanced therapeutic options and by the ability to proactively adapt to changing marketplace strategies.
Steroids for Pets Market in France is emerging with cautious but steady clinical acceptance, guided by stringent safety expectations and growing practitioner familiarity. The veterinary industry supports evidence-based use of medicines, while also focusing on minimizing the impact of safety-related concerns. As a result, thoughtful and responsible prescribing practices have developed as a result of this support. Specialty regional clinics and compounding pharmacies offer clinicians customized therapeutic options that are supportive of their successful implementation and enhanced by clinician-focused education.
Asia Pacific is strengthening its role in the steroids for pets market through a combination of expanding clinical capabilities, localized manufacturing, and increasing investment in veterinary education. Through these ongoing efforts, both countries have developed several clinically relevant research projects that can demonstrate the therapeutic value of various drugs and provide drug formulation modifications that match the local needs of clinical practice.
Additionally, other recent advances (due to better definitions of regulatory processes and accelerating the approval process for some products) are helping commercialise drugs in the local market before companies can expand their output capacity to meet the demand from local markets. One of the main ways these countries are helping to support local audiences is developing digital channels for product distribution, telehealth services so patients can access care from home, and targeted professional development to help build confidence in prescribers.
Steroids for Pets Market in Japan is characterized by sophisticated veterinary research, strong pharmaceutical capabilities, and clinically oriented practitioners. Collaborative research studies between manufacturers and hospitals help create evidence-based guidelines for formulation improvement & safety monitoring. Well-developed retail and veterinary distribution channels provide nationwide access to product availability through metropolitan areas. Continuing Education programs and consultation services through manufacturers provide veterinarians with the information needed to prescribe appropriately, enabling ongoing adoption of therapeutics for companion animals in an effective manner.
Steroids for Pets Market in South Korea is marked by rapid clinical modernization, strong domestic pharmaceutical interest and digital health integration. Veterinarians use telehealth and ecommerce in order to increase patient access and help with maintaining ongoing patient treatment. Manufacturers work with research institutions to support the adaptation of new formulations for various regions. The prescribing of medications is supported by continuing education and the Veterinary Profession's Associations. Good logistics and flexible commercial strategies ensure that veterinary practices in suburban as well as urban areas have timely access to all new medication products.
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Increasing Pet Owner Awareness
Greater awareness among pet owners of chronic inflammatory and endocrine conditions has led to more veterinary consultations and acceptance of pharmacological interventions, thereby supporting demand for steroid treatments. Programs that focus on education, the creation of online communities, and outreach to veterinarians have all contributed to helping people recognize symptoms in their pets and understand what kinds of treatment will be beneficial to them; all of this has led to many more people receiving timely treatment for their pets. As diagnostic capabilities and communication improve, pet owners are more likely to follow prescribed steroid regimens when indicated, which strengthens market uptake and supports broader availability and acceptance of steroid products in companion animal healthcare.
Advances In Veterinary Diagnostics
The ability to accurately diagnose inflammation and autoimmune diseases in companion animals, using better diagnostic tools and more accessible veterinary imaging and lab tests, allows for more accurate identification of these diseases, and thus allowing for targeted therapy using steroids. The increased clarity of diagnostic results will increase veterinarians’ confidence in recommending steroid use, and provide guidance as to the duration and dosages recommended on a case-by-case basis. This precision fosters better therapeutic outcomes and increases practitioner willingness to utilize steroid options when appropriate, which in turn accelerates acceptance and integration of steroid products into routine companion animal care.
Regulatory Safety Concerns
Tight regulatory requirements and concerns about steroid safety constrain market expansion by increasing the complexity and cost of product approval and post-market surveillance, which can slow introduction of new formulations. Due to concerns surrounding the negative impacts, long-term usage risks, and potential for abuse cause veterinarians and owners to take more care when prescribing/administering steroid medications; the resulting cautious atmosphere decreases routine prescribing/usage, limits product choice available to veterinarians from different sources and discourages manufacturers from seeking to sell into the open market beyond what is called for by the veterinary community.
Perception Of Long Term Risks
Owner perceptions towards long-term risk associated with steroidal therapies hinder the global steroids for pets market growth, as they lead to reduced owner willingness to allow their pet to receive treatment and also influence veterinarians’ search for alternative treatment options. Concerns about the potential for immunosuppression, hormonal imbalance, and quality of life create a preference for NSAIDs and conservative (non-pharmacologic) treatment approaches – especially for owners who favour natural or low-intervention care approaches. These perception-based barriers limit the number of repeat prescriptions and the adoption of newer steroid formulations, thereby hindering potential for market growth, even when there are clinical indications for appropriate steroids.
Request Free Customization of this report to help us to meet your business objectives.
Competitive rivalry in the global steroids for pets market outlook is intensifying as major animal health firms pursue targeted M&A such as Zoetis's acquisition of Nextvet, form commercialization partnerships with specialist developers, and adopt digital distribution through veterinary telemedicine. Venture stage companies advancing hormone and biologic alternatives and telehealth providers that widen prescription access are reshaping product positioning and channel competition.
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
As per SkyQuest analysis, the global steroids for pets industry is being propelled primarily by the rising prevalence of chronic inflammatory and immune-mediated conditions in companion animals and stronger owner willingness to invest in veterinary care. Nonetheless, regulatory safety regulations and exceeding concern over the long-term risks of steroids will continue to restrain the approval process from happening and create the need for careful prescribing. The major region for this category is still North America due to its well-established veterinary system and high pet owner perception coupled with a combined distribution network. The large majority of the patients are dogs with the vast majority of steroid prescriptions and specialty formulations being directed toward dogs. A second important growth driver is improved access through generics, online pharmacies and telemedicine that lower cost and expand treatment reach.
| Report Metric | Details |
|---|---|
| Market size value in 2024 | USD 1.1 Billion |
| Market size value in 2033 | USD 2.01 Billion |
| Growth Rate | 6.9% |
| Base year | 2024 |
| Forecast period | (2026-2033) |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Table Of Content
Executive Summary
Market overview
Parent Market Analysis
Market overview
Market size
KEY MARKET INSIGHTS
COVID IMPACT
MARKET DYNAMICS & OUTLOOK
Market Size by Region
KEY COMPANY PROFILES
Methodology
For the Steroids for Pets Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Steroids for Pets Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Steroids for Pets Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Steroids for Pets Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
REQUEST FOR SAMPLE
REQUEST FREE CUSTOMIZATION
Global Steroids For Pets Market size was valued at USD 1.1 Billion in 2024 and is poised to grow from USD 1.18 Billion in 2025 to USD 2.01 Billion by 2033, growing at a CAGR of 6.9% during the forecast period (2026-2033).
Competitive rivalry in the global steroids for pets market is intensifying as major animal health firms pursue targeted M&A such as Zoetis's acquisition of Nextvet, form commercialization partnerships with specialist developers, and adopt digital distribution through veterinary telemedicine. Venture stage companies advancing hormone and biologic alternatives and telehealth providers that widen prescription access are reshaping product positioning and channel competition. 'Zoetis', 'Merck Animal Health', 'Elanco', 'VytoMed', 'PetMed Express', 'Bayer Animal Health', 'Ceva Animal Health', 'VetEmergencies', 'PetSage', 'Arecibo Animal Hospital', 'PetTech Pharmaceuticals', 'VetBiologics', 'Animal Health International', 'Dechra Veterinary Products', 'Vetoquinol', 'ScanVet', 'Neogen Corporation', 'Royal Canin', 'PetIQ', 'Nutramax Laboratories'
Greater awareness among pet owners of chronic inflammatory and endocrine conditions has led to more veterinary consultations and acceptance of pharmacological interventions, thereby supporting demand for steroid treatments. Educational campaigns, online communities, and veterinarian outreach have improved recognition of symptoms and treatment benefits, encouraging timely therapy. As diagnostic capabilities and communication improve, pet owners are more likely to follow prescribed steroid regimens when indicated, which strengthens market uptake and supports broader availability and acceptance of steroid products in companion animal healthcare.
Pet Owner Preference Shift: Demand is growing for individualized treatment pathways as pet owners increasingly view companion animals as family members deserving tailored therapeutic regimens. Owners seek transparent communication about benefits and administration, prefer formulations that minimize stress and support quality of life, and prioritize products with clear veterinary endorsement. This behavior drives manufacturers to design easy to use dosing forms, educational materials, and adherence services that align clinical efficacy with owner expectations, building loyalty and enabling premium positioning through perceived value over price.
As per the global steroids for pets market analysis, North America is leading the market. The infrastructure that supports advanced animal medicine is very strong, awareness levels among owners of pets are quite high and there are many established systems that cater to distribution of the products used to treat animals.
Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.
Feedback From Our Clients
USA (+1) 351-333-4748
